Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 8591 entries
Sorted by: Best Match Show Resources per page
Augmentation method of triple phase boundary in thin film solid oxide fuel cell via physical vapor deposition.

Journal of nanoscience and nanotechnology

Park T, Chang I, Cha SW.
PMID: 24266148
J Nanosci Nanotechnol. 2013 Dec;13(12):7834-8. doi: 10.1166/jnn.2013.8102.

Triple phase boundaries (TPBs) where electrode, electrolyte, and reactant meet altogether were augmented in thin film solid oxide fuel cell when Pt cathode was deposited on yttrium-doped barium zirconate electrolyte (BZY) via sputter. The augmented TPBs were observed to...

Cite
Park T, Chang I, Cha SW. Augmentation method of triple phase boundary in thin film solid oxide fuel cell via physical vapor deposition. J Nanosci Nanotechnol. 2013;13(12):7834-8doi: 10.1166/jnn.2013.8102.
Park, T., Chang, I., & Cha, S. W. (2013). Augmentation method of triple phase boundary in thin film solid oxide fuel cell via physical vapor deposition. Journal of nanoscience and nanotechnology, 13(12), 7834-8. https://doi.org/10.1166/jnn.2013.8102
Park, Taehyun, et al. "Augmentation method of triple phase boundary in thin film solid oxide fuel cell via physical vapor deposition." Journal of nanoscience and nanotechnology vol. 13,12 (2013): 7834-8. doi: https://doi.org/10.1166/jnn.2013.8102
Park T, Chang I, Cha SW. Augmentation method of triple phase boundary in thin film solid oxide fuel cell via physical vapor deposition. J Nanosci Nanotechnol. 2013 Dec;13(12):7834-8. doi: 10.1166/jnn.2013.8102. PMID: 24266148.
Copy Download .nbib Format: NLM
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis.

PloS one

Lin C, Chen HC, Fang WH, Wang CC, Peng YJ, Lee HS, Chang H, Chu CM, Huang GS, Chen WT, Tsai YJ, Lin HL, Lin FH, Su SL.
PMID: 27657933
PLoS One. 2016 Sep 22;11(9):e0161754. doi: 10.1371/journal.pone.0161754. eCollection 2016.

BACKGROUND: Studies of angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and the risks of knee osteoarthritis (OA) have yielded conflicting results.OBJECTIVE: To determine the association between ACE I/D and knee OA, we conducted a combined case-control study and meta-analysis.METHODS: For...

Cite
Lin C, Chen HC, Fang WH, et al. Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis. PLoS One. 2016;11(9):e0161754doi: 10.1371/journal.pone.0161754.
Lin, C., Chen, H. C., Fang, W. H., Wang, C. C., Peng, Y. J., Lee, H. S., Chang, H., Chu, C. M., Huang, G. S., Chen, W. T., Tsai, Y. J., Lin, H. L., Lin, F. H., & Su, S. L. (2016). Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis. PloS one, 11(9), e0161754. https://doi.org/10.1371/journal.pone.0161754
Lin, Chin, et al. "Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis." PloS one vol. 11,9 (2016): e0161754. doi: https://doi.org/10.1371/journal.pone.0161754
Lin C, Chen HC, Fang WH, Wang CC, Peng YJ, Lee HS, Chang H, Chu CM, Huang GS, Chen WT, Tsai YJ, Lin HL, Lin FH, Su SL. Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis. PLoS One. 2016 Sep 22;11(9):e0161754. doi: 10.1371/journal.pone.0161754. eCollection 2016. PMID: 27657933; PMCID: PMC5033346.
Copy Download .nbib Format: NLM
Comparative Study of Transcriptome Profiles of Mouse Livers and Skins Infected by Fork-Tailed or Non-Fork-Tailed .

Frontiers in microbiology

Yang Y, He JJ, Hu S, Chang H, Xiang X, Yang JF, Zou FC.
PMID: 28912762
Front Microbiol. 2017 Aug 30;8:1648. doi: 10.3389/fmicb.2017.01648. eCollection 2017.

No abstract available.

Cite
Yang Y, He JJ, Hu S, et al. Comparative Study of Transcriptome Profiles of Mouse Livers and Skins Infected by Fork-Tailed or Non-Fork-Tailed . Front Microbiol. 2017;8:1648doi: 10.3389/fmicb.2017.01648.
Yang, Y., He, J. J., Hu, S., Chang, H., Xiang, X., Yang, J. F., & Zou, F. C. (2017). Comparative Study of Transcriptome Profiles of Mouse Livers and Skins Infected by Fork-Tailed or Non-Fork-Tailed . Frontiers in microbiology, 81648. https://doi.org/10.3389/fmicb.2017.01648
Yang, Yan, et al. "Comparative Study of Transcriptome Profiles of Mouse Livers and Skins Infected by Fork-Tailed or Non-Fork-Tailed ." Frontiers in microbiology vol. 8 (2017): 1648. doi: https://doi.org/10.3389/fmicb.2017.01648
Yang Y, He JJ, Hu S, Chang H, Xiang X, Yang JF, Zou FC. Comparative Study of Transcriptome Profiles of Mouse Livers and Skins Infected by Fork-Tailed or Non-Fork-Tailed . Front Microbiol. 2017 Aug 30;8:1648. doi: 10.3389/fmicb.2017.01648. eCollection 2017. PMID: 28912762; PMCID: PMC5582157.
Copy Download .nbib Format: NLM
Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.

Frontiers in immunology

Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z.
PMID: 28912784
Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017.

The 2009 H1N1 influenza (Pdm09) pandemic has been referred to as the first influenza pandemic of the twenty-first century. There is a marked difference in antigenicity between the pandemic H1N1 virus and past seasonal H1N1 viruses, which allowed the...

Cite
Peng B, Peng N, Zhang Y, et al. Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Front Immunol. 2017;8:1070doi: 10.3389/fimmu.2017.01070.
Peng, B., Peng, N., Zhang, Y., Zhang, F., Li, X., Chang, H., Fang, F., Wang, F., Lu, F., & Chen, Z. (2017). Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Frontiers in immunology, 81070. https://doi.org/10.3389/fimmu.2017.01070
Peng, Bo, et al. "Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin." Frontiers in immunology vol. 8 (2017): 1070. doi: https://doi.org/10.3389/fimmu.2017.01070
Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z. Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017. PMID: 28912784; PMCID: PMC5583165.
Copy Download .nbib Format: NLM
AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software.

F1000Research

Weiss SA, Asadi-Pooya AA, Vangala S, Moy S, Wyeth DH, Orosz I, Gibbs M, Schrader L, Lerner J, Cheng CK, Chang E, Rajaraman R, Keselman I, Churchman P, Bower-Baca C, Numis AL, Ho MG, Rao L, Bhat A, Suski J, Asadollahi M, Ambrose T, Fernandez A, Nei M, Skidmore C, Mintzer S, Eliashiv DS, Mathern GW, Nuwer MR, Sperling M, Engel J, Stern JM.
PMID: 28491280
F1000Res. 2017 Jan 10;6:30. doi: 10.12688/f1000research.10569.2. eCollection 2017.

No abstract available.

Cite
Weiss SA, Asadi-Pooya AA, Vangala S, et al. AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000Res. 2017;6:30doi: 10.12688/f1000research.10569.2.
Weiss, S. A., Asadi-Pooya, A. A., Vangala, S., Moy, S., Wyeth, D. H., Orosz, I., Gibbs, M., Schrader, L., Lerner, J., Cheng, C. K., Chang, E., Rajaraman, R., Keselman, I., Churchman, P., Bower-Baca, C., Numis, A. L., Ho, M. G., Rao, L., Bhat, A., Suski, J., Asadollahi, M., Ambrose, T., Fernandez, A., Nei, M., Skidmore, C., Mintzer, S., Eliashiv, D. S., Mathern, G. W., Nuwer, M. R., Sperling, M., Engel, J., & Stern, J. M. (2017). AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000Research, 630. https://doi.org/10.12688/f1000research.10569.2
Weiss, Shennan Aibel, et al. "AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software." F1000Research vol. 6 (2017): 30. doi: https://doi.org/10.12688/f1000research.10569.2
Weiss SA, Asadi-Pooya AA, Vangala S, Moy S, Wyeth DH, Orosz I, Gibbs M, Schrader L, Lerner J, Cheng CK, Chang E, Rajaraman R, Keselman I, Churchman P, Bower-Baca C, Numis AL, Ho MG, Rao L, Bhat A, Suski J, Asadollahi M, Ambrose T, Fernandez A, Nei M, Skidmore C, Mintzer S, Eliashiv DS, Mathern GW, Nuwer MR, Sperling M, Engel J, Stern JM. AR2, a novel automatic muscle artifact reduction software method for ictal EEG interpretation: Validation and comparison of performance with commercially available software. F1000Res. 2017 Jan 10;6:30. doi: 10.12688/f1000research.10569.2. eCollection 2017. PMID: 28491280; PMCID: PMC5399961.
Copy Download .nbib Format: NLM
Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Drugs

Chang A, Fox SH.
PMID: 27503375
Drugs. 2016 Sep;76(13):1319. doi: 10.1007/s40265-016-0624-x.

No abstract available.

Cite
Chang A, Fox SH. Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management. Drugs. 2016;76(13):1319doi: 10.1007/s40265-016-0624-x.
Chang, A., & Fox, S. H. (2016). Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management. Drugs, 76(13), 1319. https://doi.org/10.1007/s40265-016-0624-x
Chang, Anna, and Fox, Susan H. "Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management." Drugs vol. 76,13 (2016): 1319. doi: https://doi.org/10.1007/s40265-016-0624-x
Chang A, Fox SH. Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management. Drugs. 2016 Sep;76(13):1319. doi: 10.1007/s40265-016-0624-x. PMID: 27503375.
Copy Download .nbib Format: NLM
Electrodeposition of High Density Silver Nanosheets with Controllable Morphologies Served as Effective and Reproducible SERS Substrates.

Langmuir : the ACS journal of surfaces and colloids

Xia Y, Wu Y, Hang T, Chang J, Li M.
PMID: 27003754
Langmuir. 2016 Apr 12;32(14):3385-92. doi: 10.1021/acs.langmuir.6b00101. Epub 2016 Mar 31.

Silver nanosheets with a nanogap smaller than 10 nm and high reproducibility were constructed through simple and environmentally friendly electrodeposition method on copper plate. The sizes of the nanogaps can be varied from around 7 to 150 nm by...

Cite
Xia Y, Wu Y, Hang T, et al. Electrodeposition of High Density Silver Nanosheets with Controllable Morphologies Served as Effective and Reproducible SERS Substrates. Langmuir. 2016;32(14):3385-92doi: 10.1021/acs.langmuir.6b00101.
Xia, Y., Wu, Y., Hang, T., Chang, J., & Li, M. (2016). Electrodeposition of High Density Silver Nanosheets with Controllable Morphologies Served as Effective and Reproducible SERS Substrates. Langmuir : the ACS journal of surfaces and colloids, 32(14), 3385-92. https://doi.org/10.1021/acs.langmuir.6b00101
Xia, Yiqing, et al. "Electrodeposition of High Density Silver Nanosheets with Controllable Morphologies Served as Effective and Reproducible SERS Substrates." Langmuir : the ACS journal of surfaces and colloids vol. 32,14 (2016): 3385-92. doi: https://doi.org/10.1021/acs.langmuir.6b00101
Xia Y, Wu Y, Hang T, Chang J, Li M. Electrodeposition of High Density Silver Nanosheets with Controllable Morphologies Served as Effective and Reproducible SERS Substrates. Langmuir. 2016 Apr 12;32(14):3385-92. doi: 10.1021/acs.langmuir.6b00101. Epub 2016 Mar 31. PMID: 27003754.
Copy Download .nbib Format: NLM
Retraction: Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-α and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2.

Clinical science (London, England : 1979)

Shyu KG, Wang BW, Chang H.
PMID: 27634844
Clin Sci (Lond). 2016 Oct 01;130(20):1841. doi: 10.1042/CS20080215ret.

No abstract available.

Cite
Shyu KG, Wang BW, Chang H. Retraction: Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-α and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2. Clin Sci (Lond). 2016;130(20):1841doi: 10.1042/CS20080215ret.
Shyu, K. G., Wang, B. W., & Chang, H. (2016). Retraction: Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-α and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2. Clinical science (London, England : 1979), 130(20), 1841. https://doi.org/10.1042/CS20080215ret
Shyu, Kou-Gi, et al. "Retraction: Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-α and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2." Clinical science (London, England : 1979) vol. 130,20 (2016): 1841. doi: https://doi.org/10.1042/CS20080215ret
Shyu KG, Wang BW, Chang H. Retraction: Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-α and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2. Clin Sci (Lond). 2016 Oct 01;130(20):1841. doi: 10.1042/CS20080215ret. PMID: 27634844.
Copy Download .nbib Format: NLM
Early Intervention of Didang Decoction on MLCK Signaling Pathways in Vascular Endothelial Cells of Type 2 Diabetic Rats.

International journal of endocrinology

Ye S, Song Z, Li J, Li C, Yang J, Chang B.
PMID: 27703477
Int J Endocrinol. 2016;2016:6704851. doi: 10.1155/2016/6704851. Epub 2016 Sep 15.

In the study, type 2 diabetic rat model was established using streptozotocin (STZ) combined with a high-fat diet, and the rats were divided into control and diabetic groups. Diabetic groups were further divided into nonintervening, simvastatin, Didang Decoction (DDD)...

Cite
Ye S, Song Z, Li J, et al. Early Intervention of Didang Decoction on MLCK Signaling Pathways in Vascular Endothelial Cells of Type 2 Diabetic Rats. Int J Endocrinol. 2016;2016:6704851doi: 10.1155/2016/6704851.
Ye, S., Song, Z., Li, J., Li, C., Yang, J., & Chang, B. (2016). Early Intervention of Didang Decoction on MLCK Signaling Pathways in Vascular Endothelial Cells of Type 2 Diabetic Rats. International journal of endocrinology, 20166704851. https://doi.org/10.1155/2016/6704851
Ye, Shoujiao, et al. "Early Intervention of Didang Decoction on MLCK Signaling Pathways in Vascular Endothelial Cells of Type 2 Diabetic Rats." International journal of endocrinology vol. 2016 (2016): 6704851. doi: https://doi.org/10.1155/2016/6704851
Ye S, Song Z, Li J, Li C, Yang J, Chang B. Early Intervention of Didang Decoction on MLCK Signaling Pathways in Vascular Endothelial Cells of Type 2 Diabetic Rats. Int J Endocrinol. 2016;2016:6704851. doi: 10.1155/2016/6704851. Epub 2016 Sep 15. PMID: 27703477; PMCID: PMC5040811.
Copy Download .nbib Format: NLM
The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression.

American journal of translational research

Cai N, Zhou W, Ye LL, Chen J, Liang QN, Chang G, Chen JJ.
PMID: 28861175
Am J Transl Res. 2017 Aug 15;9(8):3853-3866. eCollection 2017.

Currently, there is a considerable need to develop new treatments for osteosarcoma (OS), a very aggressive bone cancer. The activation of STAT3 signaling is positively associated with poor prognosis and aggressive progression in OS patients. Our previous study reported...

Cite
Cai N, Zhou W, Ye LL, et al. The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression. Am J Transl Res. 2017;9(8):3853-3866
Cai, N., Zhou, W., Ye, L. L., Chen, J., Liang, Q. N., Chang, G., & Chen, J. J. (2017). The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression. American journal of translational research, 9(8), 3853-3866.
Cai, Nan, et al. "The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression." American journal of translational research vol. 9,8 (2017): 3853-3866.
Cai N, Zhou W, Ye LL, Chen J, Liang QN, Chang G, Chen JJ. The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression. Am J Transl Res. 2017 Aug 15;9(8):3853-3866. eCollection 2017. PMID: 28861175; PMCID: PMC5575198.
Copy Download .nbib Format: NLM
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer.

ClinicoEconomics and outcomes research : CEOR

Forde GK, Chang J, Ziogas A.
PMID: 27536150
Clinicoecon Outcomes Res. 2016 Aug 02;8:397-406. doi: 10.2147/CEOR.S91844. eCollection 2016.

OBJECTIVES: To examine the cost-effectiveness of primary debulking surgery (PDS) when compared to neoadjuvant chemotherapy (NACT) in the management of epithelial ovarian cancer (EOC) using Surveillance, Epidemiology, and End Results data linked to Medicare claims (SEER-Medicare).METHODS: Using a Markov...

Cite
Forde GK, Chang J, Ziogas A. Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. Clinicoecon Outcomes Res. 2016;8:397-406doi: 10.2147/CEOR.S91844.
Forde, G. K., Chang, J., & Ziogas, A. (2016). Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. ClinicoEconomics and outcomes research : CEOR, 8397-406. https://doi.org/10.2147/CEOR.S91844
Forde, Gareth K, et al. "Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer." ClinicoEconomics and outcomes research : CEOR vol. 8 (2016): 397-406. doi: https://doi.org/10.2147/CEOR.S91844
Forde GK, Chang J, Ziogas A. Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. Clinicoecon Outcomes Res. 2016 Aug 02;8:397-406. doi: 10.2147/CEOR.S91844. eCollection 2016. PMID: 27536150; PMCID: PMC4976818.
Copy Download .nbib Format: NLM
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines.

Vascular specialist international

Min SK, Kim YH, Joh JH, Kang JM, Park UJ, Kim HK, Chang JH, Park SJ, Kim JY, Bae JI, Choi SY, Kim CW, Park SI, Yim NY, Jeon YS, Yoon HK, Park KH.
PMID: 27699156
Vasc Specialist Int. 2016 Sep;32(3):77-104. doi: 10.5758/vsi.2016.32.3.77. Epub 2016 Sep 30.

Lower extremity deep vein thrombosis is a serious medical condition that can result in death or major disability due to pulmonary embolism or post-thrombotic syndrome. Appropriate diagnosis and treatment are required to improve symptoms and salvage the affected limb....

Cite
Min SK, Kim YH, Joh JH, et al. Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int. 2016;32(3):77-104doi: 10.5758/vsi.2016.32.3.77.
Min, S. K., Kim, Y. H., Joh, J. H., Kang, J. M., Park, U. J., Kim, H. K., Chang, J. H., Park, S. J., Kim, J. Y., Bae, J. I., Choi, S. Y., Kim, C. W., Park, S. I., Yim, N. Y., Jeon, Y. S., Yoon, H. K., & Park, K. H. (2016). Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vascular specialist international, 32(3), 77-104. https://doi.org/10.5758/vsi.2016.32.3.77
Min, Seung-Kee, et al. "Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines." Vascular specialist international vol. 32,3 (2016): 77-104. doi: https://doi.org/10.5758/vsi.2016.32.3.77
Min SK, Kim YH, Joh JH, Kang JM, Park UJ, Kim HK, Chang JH, Park SJ, Kim JY, Bae JI, Choi SY, Kim CW, Park SI, Yim NY, Jeon YS, Yoon HK, Park KH. Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int. 2016 Sep;32(3):77-104. doi: 10.5758/vsi.2016.32.3.77. Epub 2016 Sep 30. PMID: 27699156; PMCID: PMC5045251.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 8591 entries